The third quarter of 2024 brought several changes to the legislation in the pharmaceutical and healthcare sectors. Among them are the following updates:
- The EAEU has added criteria for classifying medicines as over-the-counter.
- Updated rules for conducting pharmaceutical inspections for compliance with GCP requirements.
- Unification of rules for labeling dietary supplements in the EAEU.
- A letter has been published regarding the provision of information on control materials used in in vitro diagnostics.
- The EAEU has adopted recommendations for the classification of medical devices for in vitro diagnostics.
These and other important changes are thoroughly covered by our lawyers in the new review:
Download the review
